Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 October 2018 | Story UFS | Photo Rulanzen Martin
Prof Charles Ngwena is a former professor in the UFS Department
Prof Charles Ngwena is a former professor in the UFS Department of Constitutional Law and Legal Philosophy in the Faculty of Law.

The meaning of race, culture and sexism in Africa takes a different tone than it does in the West. The West has always tried to create an identity for Africa, but the real question remains: “What does it mean to be an African?’ 

“My aim with this book was to see how discourse is formed and what it means when you say the word ‘African’, which is meaningless. You have to look back to understand how that was created,” said Prof Charles Ngwena.

Prof Ngwena’s new book, asks the critical question,‘What is Africanness?’ Fully titled, What is Africanness? Contesting nativism in race, culture and sexualities is a timely contribution to contemporary South African debates on issues of decolonisation, race, ethnicity, nation building and belonging.

Identity formation a crucial element

“The book speaks directly to African cultural heritage and deconstructs a Western-imposed and homogenising framework for understanding Africanness,” said Dr Nadine Lake from the Centre for Gender and Africa Studies (CGAS) at the University of the Free State (UFS).

Prof Ngwena foregrounds the importance of intersectionality when approaching issues of race, culture and sexuality and writes: “Genericness is ineluctably homogenising. It can serve to obscure heterogeneities among women, pre-empting the need to explore the implications of differences among women in feminist theory and praxis.

“Identity is being and becoming. It is always changing. What young people think of identity is not the same way their grandparents thought about it,” said Prof Ngwena. He added that his contribution through this book was to underlay identity formation.

The book, published by Pretoria University Law Press (PULP), was launched in a joint venture by CGAS, the Centre for Human Rights at the University of Pretoria on Tuesday 11 September 2018 at the UFS.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept